Invention Grant
- Patent Title: Oxycodone formulations
-
Application No.: US15666264Application Date: 2017-08-01
-
Publication No.: US10660886B2Publication Date: 2020-05-26
- Inventor: Benjamin Oshlack , Curtis Wright , Derek Prater
- Applicant: Purdue Pharma L.P.
- Applicant Address: US CT Stamford
- Assignee: Purdue Pharma L.P.
- Current Assignee: Purdue Pharma L.P.
- Current Assignee Address: US CT Stamford
- Agency: Davidson, Davidson & Kappel, LLC
- Main IPC: A61K31/485
- IPC: A61K31/485 ; A61K9/00 ; A61K9/16 ; A61K9/20
Abstract:
The invention is directed to sustained release formulations containing oxycodone or a pharmaceutically acceptable salt thereof which provide a mean C24/Cmax oxycodone ratio of 0.6 to 1.0 or 0.7 to 1 after oral administration at steady state to patients and methods thereof.
Public/Granted literature
- US20170340626A1 OXYCODONE FORMULATIONS Public/Granted day:2017-11-30
Information query
IPC分类:
